Skip to main content
Log in

In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry

  • Diagnostic Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Introduction

Assessment of brain tumor proliferative potential provides important prognostic information that supplements standard histopathologic grading. Proton magnetic resonance spectroscopy (1H-MRS) gives completely different information, relating to cell membrane proliferation, neuronal damage, energy metabolism and necrotic transformation of brain or tumor tissues. The aim of this study was to investigate the relationship between 1H-MRS and tumor proliferative potential in astrocytomas.

Methods

We studied 34 patients with histologically verified astrocytomas using the 1H-MRS protocol following routine MRI preoperatively. The tumor in 26 of these patients was classified as grade I/II (low grade), and the tumor in the remaining patients as grade III/IV (high grade) according to the World Health Organization classification criteria of nervous system tumors (2000). The tumor in 21 patients was homogeneous astrocytoma, and of these 17 were classified as low grade and 4 as high grade. Expression of proliferating cell nuclear antigen (PCNA) was determined immunohistochemically using streptavidin-biotin-peroxidase complex (SP) staining.

Results

The ratios of choline (Cho) to N-acetylaspartate (NAA) and Cho to creatine (Cr) in those with high-grade astrocytomas (n=4) were significantly higher than in those with low-grade astrocytomas (n=17) (t=2.899, P=0.009; t=3.96, P=0.001, respectively), and were found to be significantly correlated with the expression of PCNA in 21 patients with homogeneous astrocytomas (r=0.455, P=0.038; r=0.633, P=0.002, respectively).

Conclusions

We conclude that 1H-MRS may be a valuable method for predicting preoperatively the degree of malignancy of homogeneous astrocytomas by enabling the calculation of the Cho/NAA and Cho/Cr ratios in vivo, and indirect evaluation of the tumor proliferative potential and prognosis, which are not available using conventional magnetic resonance imaging (MRI).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Wu JM, Cai XD, Fu YZ (2000) Research in the expression of proliferating cell nuclear antigen in the malignant progress of astrocytomas (in Chinese). Chin J Neurosurg 16:187–189

    Google Scholar 

  2. Chen CQ, Wang XY, Chen C (1999) The relative study between the manifestation in magnetic resonance imaging and the expression of proliferating cell nuclear antigen in supratentorial astrocytomas (in Chinese). Chin J Radiol 33:561–564

    Google Scholar 

  3. Magalhaes A, Godfrey W, Shen Yimin, Hu Jiani, Smith W (2005) Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Acad Radiol 12:51–57

    Article  PubMed  Google Scholar 

  4. Izumiyama H, Abe T, Tanioka D, Fukuda A, Kunii N (2004) Clinicopathological examination of glioma by proton magnetic resonance spectroscopy background. Brain Tumor Pathol 21:39–46

    Article  PubMed  CAS  Google Scholar 

  5. Möller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381

    Article  PubMed  Google Scholar 

  6. Ott D, Hennig J, Ernst T (1993) Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 186:745–752

    PubMed  CAS  Google Scholar 

  7. Cendes F, Leproux F, Melanson D, Ethier R, Evans A, Peters T, Andermann F (1993) MRI of amygdala and hippocampus in temporal lobe epilepsy. J Comput Asist Tomogr 17:206–210

    Article  CAS  Google Scholar 

  8. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di Chiro G (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516–524

    Article  PubMed  CAS  Google Scholar 

  9. Fountas KN, Kapsalaki EZ, Vogel RL, Fezoulidis I, Robinson JS, Gotsis ED (2004) Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 82:90–97

    Article  PubMed  Google Scholar 

  10. Yang D, Korogi Y, Sugahara T, Kitajima M, Shigematsu Y, Liang L, Ushio Y, Takahashi M (2002) Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44:656–666

    Article  PubMed  CAS  Google Scholar 

  11. Lehnhardt FG, Bock C, Röhn G, Ernestus RI, Hoehn M (2005) Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed 18:371–382

    Article  PubMed  CAS  Google Scholar 

  12. Shimizu H, Kumabe T, Shirane R, Yoshimoto T (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21:659–665

    PubMed  CAS  Google Scholar 

  13. Luyten PR, Marien AJ, Heindel W, van Gerwen PH, Herholz K, den Hollander JA, Friedmann G, Heiss WD (1990) Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 176:791–799

    PubMed  CAS  Google Scholar 

  14. Curtis MA, Penney EB, Pearson AG, van Roon-Mom WM, Butterworth NJ, Dragunow M, Connor B, Faull RL (2003) Increased cell proliferation and neurogenesis in the adult human Huntington’s disease brain. Proc Natl Acad Sci U S A 100:9023–9027

    Article  PubMed  CAS  Google Scholar 

  15. Yue H, Na YL, Feng XL, Ma SR, Song FL, Yang B (2003) Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer. World J Gastroenterol 9:377–380

    PubMed  CAS  Google Scholar 

  16. Bian XW, Shi JQ, Liu FX (2000) Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors. Anal Quant Cytol Histol 22:429–437

    PubMed  CAS  Google Scholar 

  17. Kirkegaard LJ, DeRose PB, Yao B, Cohen C (1998) Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas, Prognostic significance. Am J Clin Pathol 109:69–74

    PubMed  CAS  Google Scholar 

  18. Korkolopoulou P, Christodoulou P, Lekka-Katsouli I, Kouzelis K, Papanikolaou A, Panayotides I, Mariatos P, Thomas-Tsagli E, Crocker J (1994) Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in gliomas. Histopathology 25:349–355

    Article  PubMed  CAS  Google Scholar 

  19. Nafe R, Herminghaus S, Pilatus U, Hattingen E, Marquardt G, Schlote W, Lanfermann H, Zanella F (2004) Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy. Neuropathology 24:172–182

    Article  PubMed  Google Scholar 

  20. Sharma M, Ralte A, Arora R, Santosh V, Shankar SK, Sarkar C (2004) Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Pathology 36:139–144

    Article  PubMed  CAS  Google Scholar 

  21. Korshunov A, Golanov A, Sycheva R (2002) Immunohistochemical markers for prognosis of cerebral glioblastomas. J Neurooncol 58:217–236

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, J., Huang, SL., Li, T. et al. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry. Neuroradiology 48, 312–318 (2006). https://doi.org/10.1007/s00234-006-0066-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-006-0066-3

Keywords

Navigation